Inflammation and fibrosis in patients with atrial fibrillation and heart failure: is there a need for rehabilitation?

Background: Atrial fibrillation (AF) is increasingly prevalent among the general population as well as in those exhibiting heart failure (HF), and the symptomatology progressively worsens when both conditions are met. The aim of this study was to analyse the role of inflammation and fibrosis biomark...

Full description

Saved in:
Bibliographic Details
Published in:Balneo and PRM Research Journal (Online. English ed.) 2023-09 (Vol.14, no.3), p.568
Main Authors: Frîngu, Florina, Tomoaia, Raluca, Caloian, Bogdan, Zdrenghea, Dumitru, Irimie, Diana, Comsa, Horatiu, Simu, Gelu, Dădrlat-Pop, Alexandra, Pop, Dana, Guşetu, Gabriel
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Atrial fibrillation (AF) is increasingly prevalent among the general population as well as in those exhibiting heart failure (HF), and the symptomatology progressively worsens when both conditions are met. The aim of this study was to analyse the role of inflammation and fibrosis biomarkers in patients with AF and HF. Methods: 108 subjects with heart failure were enrolled in the study. All patients were evaluated clinically, biologically and echocardiographically. Plasma values of NTproBNP, Gal-3 and sST2 were determined. Results: Out of all patients, 64.8% experienced at least one AF event. There were no differences in the mean left ventricular ejection fraction between the groups, which was 39.4 ± 11.2%. In terms of left atrium dimensions, the values in the AF group were significantly higher ( 51.19 ± 7.3 vs. 44.68 ± 7.16 mm, p
ISSN:2734-844X
2734-8458
DOI:10.12680/balneo.s2023.568